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So far, there is no genome-wide estimation of the mutational spectrum in humans. In this study, we systematically examined the directionality
of the point mutations and maintenance of GC content in the human genome using ∼1.8 million high-quality human single nucleotide
polymorphisms and their ancestral sequences in chimpanzees. The frequency of C→T (G→A) changes was the highest among all mutation types
and the frequency of each type of transition was approximately fourfold that of each type of transversion. In intergenic regions, when the GC
content increased, the frequency of changes from G or C increased. In exons, the frequency of G:C→A:T was the highest among the genomic
categories and contributed mainly by the frequent mutations at the CpG sites. In contrast, mutations at the CpG sites, or CpG→TpG/CpA
mutations, occurred less frequently in the CpG islands relative to intergenic regions with similar GC content. Our results suggest that the GC
content is overall not in equilibrium in the human genome, with a trend toward shifting the human genome to be AT rich and shifting the GC
content of a region to approach the genome average. Our results, which differ from previous estimates based on limited loci or on the rodent
lineage, provide the first representative and reliable mutational spectrum in the recent human genome and categorized genomic regions.
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many factors such as sequence context, methylation of CpG
dinucleotides, and categorized genomic regions [1–5]. One
long-standing interest has been to examine the directionality of
point mutation and to explore how nucleotide changes shift the
nucleotidecomposition in thedifferent regionsofgenomes [6–8].
Early studies of 13 mammalian pseudogene sequences revealed
that themutationdirectionisnonrandom[6,7].Othersurveysfrom
noncoding regions indicated that G/C to A/T (G/C→A/T)
changes might occur more frequently than A/T→G/C changes
(e.g., Ref. [9]), suggesting that human noncoding and pseudo-
gene sequences have the tendency to become AT-rich. However,
these estimates were based on a very limited number of loci and
their observations were often inconsistent [10,11].Moreover, the⁎ Corresponding author. Virginia Institute for Psychiatric and Behavioral
Genetics, Virginia Commonwealth University, P.O. Box 980126, Richmond, VA
23298-0126, USA. Fax: +1 804 828 1471.
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doi:10.1016/j.ygeno.2006.06.003frequencies of a pair of nucleotide changes based on the DNA
strand symmetry, e.g., G→Aversus C→T,were not observed to
be nearly the same as expected [7]. So far, there is no systematic
estimation of the mutational spectrum in the human genome or
categorized genomic regions (e.g., intergenic regions, exons,
introns, CpG islands).
The GC content in the nonrepetitive fraction of the human
genome is ∼40.31%; this is lower than that in the mouse
(∼41.26%) and rat (∼41.61%) genomes [12]. Cooper et al. [12]
recently inferred the direction of the nucleotide substitutions in
the mouse and rat lineages based on large-scale alignments of
human, mouse, and rat genomic sequences. Their results showed
an excess of A/T→G/C changes (50.3% in rats and 47.2% in
mice) over G/C→A/T (35.0% in rats and 37.9% in mice).
Although their results determined a relative increase in GC
content in the rat genome, the excess of AT→GC in rodents is
opposite to what has been previously observed in noncoding or
pseudogene sequences; thus, further investigations are war-
ranted. Moreover, rats and mice diverged∼12–24 million years
Table 1
Proportion of inference in each case by ENCODE data
SNP category Case 1 a Case 2 or 3 Case 4
Transition (33,302 b) 0.86 0.03 0.11
Transversion (16,645) 0.90 0.07 0.04
Total (49,947) 0.87 0.04 0.09
a Four cases are illustrated in Fig. 1.
b Number of SNPs.
528 C. Jiang, Z. Zhao / Genomics 88 (2006) 527–534(Myr) ago from their common ancestor, while humans and mice
diverged ∼75 Myr ago [13]. Such a cross-species comparison
has limitations in inferring the mutation direction in the human
genome because recurrent mutationsmay have occurred after the
divergence of humans and rodents. Indeed, higher substitution
rates were found in the rodent lineage compared to the human
lineage and only a small portion of these genomes could be
aligned, e.g.,∼30% of the rat genome was aligned to the mouse
genome [13].
At present, more than 10 million single nucleotide poly-
morphisms (SNPs) have been discovered in the human genome.
This provides us with an alternative approach to examine the
mutation patterns in the human genome. The mutation direction
for each SNP can be inferred by comparing the SNP with its
outgroup chimpanzee sequences. This approach is unique since
the mutation direction inferred by a SNP and its outgroup
sequence is likely to be true because the divergence time
between humans and chimpanzees is ∼6 Myr ago and most
SNPs occurred in a relatively recent time period, i.e., less than 1
Myr ago [9,14]. This should provide more reliable estimates
than roughly comparing the aligned genomic sequences. The
major limitation is that these polymorphic sites account for only
a small portion (∼0.3%) of the human genome.
In this study, we first evaluated whether we could infer the
mutation direction by comparing human SNPs with chimpanzee
sequences only, an approach that has been commonly accepted
but never evaluated. This evaluation was conducted by com-
paring the SNPs in 44 ENCODE regions [15] with two outgroup
species, the chimpanzee and baboon. We next systematically
inferred the mutation direction in the human genome and
categorized genomic regions by comparing two alleles of each
human SNP with its ancestral chimpanzee sequence. Finally, weFig. 1. Inference of mutation direction for human SNPs by maximum parsimony
principle. In this example, a human SNP (A/T) has its corresponding
chimpanzee (Chimp) allele A. In the first case, the baboon carries the same
allele as the chimpanzee (i.e., A). Only one mutation event is needed and this
occurred in the branch from node 2 to human. The mutation direction is thus
inferred to be A→T. In the second and third cases, the baboon carries an allele
(C or G) that is different from both human alleles (A and T). A minimum of two
mutational events are needed. However, node 2 should always be allele A no
matter how the nucleotide changes in the branches from 1 to 2 or from 1 to
baboon. Thus, the mutation direction is inferred to be A→T. In the last case, the
baboon carries an allele T. At least two mutational events are needed, but the
allele at node 2 cannot be resolved and the mutation direction cannot be inferred.compared the frequencies of G/C→A/T versus A/T→G/C
changes and found that the GC content in the human genome
was overall not in equilibrium. This study provides a
comprehensive genome-wide view of the mutation patterns in
recent human history.
Results
Inference of mutation direction by ENCODE data
In this study, we inferred the mutation direction of a human
SNP by comparing it with its chimpanzee ancestral allele. We
first evaluated the reliability of this approach. We retrieved
95,353 human SNPs in 44 ENCODE regions from the UCSC
ENCODE browser (http://genome.ucsc.edu/ENCODE/).
Among them, 49,947 SNPs were selected because one of their
two alleles matched the chimpanzee allele. The mutation
direction was inferred by the maximal parsimony principle
when these SNPs were compared with their corresponding
ancestral alleles in chimpanzees using the baboon as an addi-
tional outgroup reference (see Materials and methods). Fig. 1
illustrates four possible cases in the inference of mutation
direction for one SNP type (A/T). Table 1 summarizes the
proportion of inference in each case for transition, transversion,
and all SNPs. Among the 49,947 SNPs analyzed, 87% could be
inferred in case 1 and 4% in cases 2 and 3. This accounts for 91%
that could be reliably inferred by comparing the ancestral
information only in chimpanzees without any other outgroup
reference. The proportion was higher for transversional
changes (97%) than for transitional changes (89%). This
difference was further seen for each SNP category (i.e., A/G,
C/T, A/C, G/T, A/T, and C/G; Supplementary Table S1). The
higher proportion in case 4 for transitional SNPs might reflect
the high transition rate and hypermutability of methylated CpG
dinucleotides in vertebrate genomes [16].
According to the maximal parsimony principle, there would
be two mutational events in case 4. One mutation would have
always occurred in the branch from node 2 to human in Fig. 1.
The other mutation might have occurred in one of the other three
branches: from node 2 to chimpanzee, from node 1 to node 2,
and from node 1 to baboon. Only when the mutation occurred in
the branch from node 2 to chimpanzee would the mutation
direction inferred be different from that in cases 1–3, i.e., T→A.
Since the divergence time between humans and chimpanzees
(∼6 Myr) is much shorter than that between humans and
baboons (∼25 Myr) [17,18], assuming the constant point
mutation rate in these branches, the probability that the mutation
occurred in the branch from node 2 to chimpanzee would be the
Table 2
Frequencies (%) of nucleotide changes in the human genome and categorized genomic regions
Category GC (%) a No. of SNPs A→G T→C G→A C→T A→C T→G G→T C→A A→T T→A G→C C→G
Genome 40.31 1,785,712 16.7 16.7 17.4 17.4 4.0 4.0 4.2 4.2 3.3 3.3 4.4 4.4
Intergenic regions 40.18 1,142,121 16.8 16.8 16.9 17.0 4.1 4.1 4.3 4.3 3.5 3.5 4.4 4.3
Genes 42.28 339,005 16.6 16.7 18.2 18.1 4.0 3.9 3.8 3.8 2.9 3.0 4.5 4.6
Introns 41.72 418,086 16.8 16.9 17.8 17.8 4.0 4.0 3.8 3.8 3.1 3.1 4.6 4.5
Exons 52.10 12,430 12.2 12.2 26.7 25.5 2.3 2.1 3.2 3.5 1.8 1.7 4.1 4.8
CpG islands 62.07 25,913 9.0 9.0 22.1 22.4 2.6 2.7 6.5 6.1 1.9 2.0 7.8 7.9
Promoter CpG islands 63.38 2731 8.0 9.3 21.7 21.6 2.9 2.8 6.6 6.5 2.0 1.9 8.5 8.2
a The average GC content in the sequences we analyzed.
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(87%+4%+(9%/2)) reliability. In summary, this evaluation
indicates that it is very reliable to infer the mutation direction by
comparing human SNPs with their chimpanzee sequences only.
Mutational spectrum in the human genome
A total of 1,785,712 human SNPs could be mapped to the
chimpanzee genome based on the MegaBLAST search results
using the stringent criteria described under Materials and
methods. The ancestral alleles of these SNPs were obtained
from the alignments. Table 2 summarizes the inferred mutation
directions of these SNPs. In the nonrepetitive sequences across
the human genome, which is shown in the first row of Table 2,
the frequency of each transitional type (e.g., G→A) was
∼17%, approximately fourfold that for each transversional
type. The most frequently observed nucleotide change was
C→T (G→A), which, on average, was 17.4% among all
mutations. The frequency of G→Awas nearly the same as that
of C→T, reflecting the complementary DNA strand symmetry.
This feature was also observed in other pairs of nucleotide
changes (e.g., A→C and T→G). Moreover, the frequency of
C→T (G→A) was slightly higher than that of T→C (A→G).
We note that the GC content in the nonrepetitive genomic
sequences used in this study was 40.31% (Table 2). Therefore,
the differences above were larger after the GC content was
normalized to be 50% (data not shown). Finally, among all
nucleotide changes, A→T (T→A) changes were the least
frequently observed.
Throughout the remaining text, we shall denote G:C→A:T
for the pair of mutations G→A and C→T. The other pairs will
follow the same rules.Table 3
Frequencies (%) of nucleotide changes in intergenic regions
GC (%) a No. of SNPs A:T→G:C G:C→A:T
<35 (31.36) b 205,817 38.1 28.2
35–40 (37.31) 179,725 35.4 32.1
40–45 (42.20) 127,842 32.5 35.4
45–50 (47.18) 75,491 28.8 40.1
50–55 (52.21) 44,242 25.1 45.1
55–60 (57.20) 25,170 22.1 48.3
≥60 (63.92) 15,444 19.0 49.7
a GC content in a nonrepetitive intergenic region was obtained in a window with
b The average GC content (%) in the subcategory of intergenic regions.Mutational spectrum in the categorized genomic regions
Table 2 also includes the mutation direction among the
categorized genomic regions. The results are summarized as the
following four points. First, the mutational spectrum observed
in intergenic regions was not much different from that of the
whole genome. This is likely due to the large portion of
intergenic regions (and introns as well, Table 2) in the human
genome. Second, in genic regions, in which GC content
(42.28%) was higher than in intergenic regions (40.18%), the
frequency of G:C→A:T was moderately higher than that in
intergenic regions. This contrasts with a slightly lower
frequency of A:T→G:C in genic regions than in intergenic
regions. For the transversional changes, except for G:C→C:G,
the frequency of each type in genic regions was lower than that
in intergenic regions. Third, in exonic regions where the GC
content was averaged to be 52.10%, the frequencies of C→T
and G→A were 25.5 and 26.7%, respectively. These
frequencies stand out as the highest among all categories,
even higher than those in the CpG island sequences, which had
the highest GC content (62.07%) among the genomic
categories. This resulted in lower frequencies of other mutation
types, except for G:C→C:G, in exons than in introns.
Finally, in the CpG island sequences mutations from
nucleotide G or C to any other nucleotide dominated. For
example, G:C→T:A and G:C→C:G had the highest frequen-
cies among the categories. We further analyzed those CpG
islands located in the promoter regions. While the mutational
spectrum was overall similar to that in the CpG islands, a
lower frequency of G:C→A:T was observed, reflecting the
absence of the CpG effects in the promoter-associated CpG
islands (Table 2).A:T→C:G G:C→T:A A:T→T:A G:C→C:G
9.5 8.2 8.6 7.3
8.5 8.4 7.1 8.5
7.8 8.7 6.3 9.3
6.8 9.0 5.3 10.0
6.0 9.1 4.5 10.3
5.0 9.6 3.8 11.3
4.7 10.9 3.0 12.6
a size of 500 nucleotides.
Fig. 2. Linear regression of the frequency of each mutational type versus GC
content in intergenic regions. Intergenic regions were subgrouped into seven
GC-content bins. (A) Linear regression of the frequency of G:C→A:T (○,
R2=0.98, p<0.0001) and A:T→G:C (●, R2=0.99, p<0.0001) versus GC
content. (B) Linear regression of the frequency of G:C→T:A (○, R2=0.86,
p=0.003), G:C→C:G (▿, R2=0.99, p<0.0001), A:T→C:G (●, R2=0.98,
p<0.0001), and A:T→T:A (▾, R2=0.98, p<0.0001) versus GC content. A
different scale was used on the y axis in A and B.
Fig. 3. Frequency of G:C→A:T mutations among the genomic categories.
White bar, original frequency; gray bar, after removal of the CpG sites; black
bar, after removal of CpG→TpG/CpA.
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To test whether the mutational spectrum depends on the GC
content we further examined the intergenic regions with
different GC content since mutations in this category are
usually assumed to be selectively neutral. Table 3 shows the
mutational spectrum in each subcategory of intergenic regions.
Since the frequencies of the two types in each pair were nearly
the same, we combined each pair to save space. The results
indicate that when GC content increased, the frequencies of
changes from C or G to any other nucleotide increased;
conversely, the frequencies from A or T to any other nucleotide
decreased. A further statistical analysis indicated a significant
positive correlation between any mutation type from G/C (i.e.,
G:C→A:T, G:C→T:A, G:C→C:G) and GC content and,
conversely, a significant negative correlation between any
mutation type from A/T (i.e., A:T→G:C, A:T→C:G, A:T→T:
A) and GC content (Fig. 2). The extent of the changes was
stronger in the transitional types than in the transversional types.
For example, the frequency of G:C→A:T changes increasedfrom 28.2 (GC content <35%) to 49.7% (GC content ≥60%).
Correspondingly, the transition over transversion ratio increased
when the GC content increased.
Mutational spectrum after excluding the CpG effects
The mutation rate of methylated CpG to TpG/CpA was
estimated to be 10–50 times higher than other transitional
changes [16]. Such CpG effects elevate the frequency of G:
C→A:T or, more specifically, CpG→TpG/CpA. To examine
the CpG effects on the mutational spectrum in the human
genome, we compared the mutation direction by (1) removing
the SNPs that occurred at the CpG sites and (2) removing
CpG→TpG/CpA. These results are shown in Supplementary
Tables S2 and S3, respectively. As expected, the frequency of
G:C→A:T decreased drastically among all categories after
removal, and the extent of the decrease in G:C→A:T after
removal of CpG→TpG/CpAwas stronger than after removal of
the CpG sites. Conversely, the frequencies of all other changes,
except for G:C→T:A and G:C→C:G in the (promoter) CpG
islands, increased. This resulted in a smaller frequency
difference among mutation types. For the total SNPs, the
frequency of G:C→A:T decreased from 34.8 to 26.8% after
removal of the CpG sites and to 26.4% after removal of
CpG→TpG/CpA. This decrease was similarly observed in
intergenic and intronic regions (Fig. 3).
Exonic regions showed the strongest decrease among the
categories (Fig. 3). The frequency of G:C→A:T decreased by
17.1% when the CpG sites were removed and by 18.6% when
CpG→TpG/CpA mutations were removed. The decrease was
more than twofold that in intergenic regions and nearly twofold
that in introns (Table 2, Supplementary Tables S2 and S3). We
next compared the extent of the decrease in exons with that in
intergenic regions with similar GC content (50–55%). The
results indicate that the extent of the decrease after removal was
much stronger in exons than in intergenic regions (Fig. 4A).
Interestingly, in the CpG islands, the frequency of G:C→A:
T decreased by only 7.6% after removal of the CpG sites, much
less than the 12.4% decrease after removal of CpG→TpG/
CpA. This difference became even smaller, i.e., 5.6 and 10.4%,
respectively, when we examined the promoter-associated CpG
Table 4
Mutations between nucleotides G/C and A/T in the human genome
Category GC (%) G/C→A/T (%) A/T→G/C (%) u/v (1 – PGC)/PGC
Genome 40.31 43.1 41.4 1.54 1.48
Intergenic 40.18 42.5 41.8 1.52 1.49
Gene 42.28 43.9 41.1 1.46 1.37
Introns 41.72 43.2 41.7 1.45 1.40
Exons 52.10 59.0 28.8 1.89 0.92
CpG
islands
62.07 57.0 23.3 1.49 0.61
Promoter
CpG
islands
63.38 56.4 22.9 1.42 0.58
Fig. 4. Effects of mutations at the CpG sites. (A) Frequency changes in exons
and CpG islands after removal of the CpG sites or CpG→TpG/CpA. Frequency
difference between the original data and after removal of CpG sites is labeled in
gray and frequency difference between the original data and after removal of
CpG→TpG/CpA is labeled in black. (B) Frequency of CpG→TpG/CpA
mutations at the CpG sites.
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islands with that in intergenic regions with similar GC content
(55–75%). In Fig. 4A, the extent of the decrease is much
smaller in the (promoter-associated) CpG islands than in the
corresponding intergenic regions when the CpG sites were
removed (12.9%). However, the extent of the decrease became
less remarkable (e.g., 12.4% in the CpG islands vs 14.9% in
intergenic regions) when CpG→TpG/CpA mutations were
removed. This indicated that mutations other than CpG→TpG/
CpA (e.g., CpG→GpG/CpC) at the CpG sites may occur more
frequently in the CpG islands than in other genomic regions.
Indeed, this was confirmed when we compared the frequency of
CpG→TpG/CpA at the CpG sites (Fig. 4B).
GC content disequilibrium in the human genome
Each nucleotide at a site may change to any of the other three
nucleotides. Based on the 1,785,712 SNPs in this study, the
frequencies of mutations from nucleotide A, T, C, or G to any
other nucleotide were 24.0, 24.0, 26.0, and 26.0%, respectively.
And thesemutations resulted in nucleotides A, T, C, andG by the
frequencies 24.8, 24.9, 25.2, and 25.1%, respectively. Further,
the frequency of G/C→A/T was 43.1% among all mutations,
higher than that (41.4%) of A/T→G/C. This indicated that, in
the recent human genome, there is a trend to have more G or C
changes to A or T. This trend was found among all genomiccategories (Table 4), suggesting that the point mutations may
tend to decrease GC content across the human genome.
We next examined whether the GC content in the human
genome has been under statistical equilibrium. If selection is not
considered, the mean GC content at equilibrium (PGC) is
expected to be
PGC ¼ v=ðuþ vÞ; ð1Þ
where u and v are the rates of G/C→A/T and A/T→G/C,
respectively [19]. This equation can be transformed to
u=v ¼ 1 PGC
PGC
ð2Þ
For SNP data,
u=v ¼ Nu=fGC
Nv=ð1 fGCÞ ¼
Nu
Nv
 1 fGC
fGC
ð3Þ
where Nu and Nv are the numbers of G/C→A/Tand A/T→G/C,
respectively, and fGC is the GC content. Eq. (3) becomes Eq. (2)
when Nu is close to Nv, which is under the GC content
equilibrium. In Table 4, the u/v ratio was 1.54 in the whole
genome, which is nearly the same as the expected (1.48) from the
GC content at equilibrium. This pattern was similarly found in
intergenic and intronic regions. However, the u/v ratio was 1.89
in exons, twice the expected value (0.92). In the CpG islands, the
u/v ratio was more than twofold the expected (0.61). In theory,
the expected u/v ratio at equilibrium decreases when GC content
increases and becomes less than 1 when GC content is higher
than 50%. These results suggest, assuming there is no selection,
that (1) the GC content in the overall genome, intergenic, or
intronic regions is nearly at equilibrium (reexamined in the next
paragraph); (2) the GC content in exons and CpG islands is not
under equilibrium, with a trend to decrease the GC content; and
(3) the point mutations created slightly more G/C→A/T than
expected in the overall genome, intergenic, or intronic regions,
but much more G/C→A/T in exons and CpG islands.
We next examined the u/v ratios in intergenic regions by
different GC content. Table 5 shows that the observed u/v ratio
was much smaller than the expected when the GC content was
low (e.g., <35%), then became close to the expected when the
GC content was close to the genome average, and finally,
became greater than the expected when the GC content was
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whose GC content was very close to the genome average (e.g.,
38–39, 39–40, 40–41, 41–42%) further enhanced this trend
(data not shown). The results clearly indicate that the overall
observations in Table 4 were not sufficient and the GC content in
intergenic regions was not in equilibrium. This implies that the
human genome is overall not in equilibrium, with a trend for the
GC content of a region to approach the human genome average.
Discussion
We have examined the directionality of the point mutations
and maintenance of GC content in the human genome and
categorized genomic regions using ∼1.8 million high-quality
SNPs and their ancestral information. In the human genome, the
frequency of C→T (G→A) was 17.4%, which is higher than
that (16.7%) of T→C (A→G). The frequency of each type of
transition was approximately fourfold that of each type of
transversion. In intergenic regions, when the GC content
increased, the frequencies of mutations from G or C (G:C→A:
T, G:C→T:A, G:C→C:G) increased and, conversely, the
frequencies of mutations from A or T (A:T→G:C, A:T→C:G,
and A:T→T:A) decreased. In exons, the frequency of G:C→A:
T was the highest among the genomic categories. This was
contributedmainly by the “excess”mutations at the CpG sites. In
contrast, mutations at the CpG sites, or CpG→TpG/CpA
mutations, occurred less frequently in the CpG islands compared
with similar intergenic regions. Further, the mutations other than
CpG→TpG/CpA at the CpG sites may occur more frequently in
the CpG islands. The comparison of the rates of G/C→A/T and
A/T→G/C suggests that GC content is generally not under
equilibrium in the genome. Because most SNPs occurred
recently, these results provided a detailed view of the mutational
spectrum in the recent human genome. Critically, our estimates
provide an updated and reliable mutational spectrum in the
human genome.
The frequencies of nucleotide changes in this study were
different from the previous estimates by other approaches. First,
we compared our results with those based on the 13 mammalian
pseudogene sequences [6,7]. Because those results were
presented by relative substitution frequencies, for comparison
purposes, we recalculated their data by the frequency of each
mutation type among all observed mutations (Supplementary
Table S4). The frequencies of G→A (22.2%), C→T (20.8%),
G→T (7.7%), and C→A (6.5%) were much higher than those
of our results, whether in the whole genome, intergenic, orTable 5
Mutations between nucleotides G/C and A/T in intergenic regions
Category GC (%) G/C→A/T (%) A/T→G/C (%) u/v (1 – PGC)/PGC
<35% 31.36 36.5 47.6 1.67 2.19
35–40% 37.31 40.6 43.8 1.55 1.68
40–45% 42.20 44.1 40.3 1.50 1.37
45–50% 47.18 49.1 35.6 1.54 1.12
50–55% 52.21 54.1 31.1 1.59 0.92
55–60% 57.20 57.9 27.1 1.60 0.75
≥60% 63.92 60.7 23.7 1.44 0.56intronic regions (Table 2). Conversely, the frequencies of A→G
(8.7%) and T→C (8.0%) were much lower than our results. In
those pseudogene sequences, the frequencies in each pair (e.g.,
A→C and T→G) were not nearly the same as expected,
indicating that these estimates were not reliable due to the small
number of loci. Second, we compared our results with those
from the human SNPs in chromosome 21 [14]. Our reanalysis of
their 19,985 SNPs indicated a slightly different mutational
spectrum from the one based on our 30,191 SNPs in the same
chromosome. However, the mutational spectrum in chromo-
some 21 was different from the global spectrum in our study,
indicating its insufficiency to represent the human genome
(Table 2 and Supplementary Table S4). From the data in
Watanabe et al. [14], we also found the frequency of G:C→A:T
to be lower than that of A:T→G:C, though the opposite has
been widely observed previously, as well as in this study [7,9].
This might be due to the small number of SNPs used, the criteria
of selection of SNPs in their study, or both. Third, a recent
estimate of the mutational spectrum based on the global
alignments of human, mouse, and rat genomic sequences
indicated that the frequency of G/C→A/Twas 35.0% in the rat
lineage and 37.9% in the mouse lineage [12]; both were less
than the 43.1% estimated based on our human SNPs and the
43.4% estimated based on chimpanzee SNPs (unpublished
results). Among them, the frequency of G:C→A:T was 28.3
(rat), 30.7 (mouse), 34.8 (human), and 35.3% (chimpanzee).
Interestingly, this trend was just the opposite of the GC content
in the nonrepetitive fraction of these four genomes: 41.61 (rat),
41.26 (mouse), 40.31 (human), and 40.02% (chimpanzee) [12].
This may, at least partially, explain the GC content difference in
these four genomes.
Our analysis of the mutation patterns based on the SNPs
revealed that the GC content is not in equilibrium in the recent
human genome. Overall, we observed more G/C→A/T than A/
T→G/C mutations, no matter which genomic categories we
examined (Table 4). This suggests that the human genome has
currently been shifting toward being AT-rich, given that
selection is not an factor. Our further analysis of the u/v ratio
in intergenic regions revealed a surprising trend: the regions
with lower GC content tend to have a lower u/v ratio than the
expected and the regions with higher GC content tend to have a
higher u/v ratio than the expected. Moreover, we found that the
observed u/v ratios in exons and CpG islands were much higher
than the expected, suggesting their GC content might become
lower by point mutations. A recent study supporting this found
a 30–60% higher mutation rate in exons than in the noncoding
regions, due mainly to the overabundance of synonymous sites
involving the CpG dinucleotides in exons [3]. In the CpG
islands, evidence was found to support a loss of ancestral CpG
islands in the mouse and human genomes ([20,21] and
unpublished results). In this “loss of CpG islands” model,
CpG dinucleotides in some islands might become de novo
methylated and thus more likely to be mutated to TpG because
of the hypermutability of the methylated CpG dinucleotides.
Furthermore, the strong difference between the observed u/v
ratios and the expected values in exons and CpG islands might
also be due to selection pressure and gene conversion [1,8].
533C. Jiang, Z. Zhao / Genomics 88 (2006) 527–534One important issue is how reliable our analysis is. In this
study, we applied stringent criteria for the selection of SNPs and
mapping of the human SNPs to the chimpanzee genome.
Among 8,353,499 available SNPs, we selected only the SNPs
that satisfied the following criteria: (1) non-insertion/deletion,
(2) biallelic, (3) validated, (4) longer than 100 nucleotides at
each flanking side, (5) uniquely mapped in the human non-
repetitive sequences, and (6) uniquely mapped in the chimpan-
zee genome. To determine whether a human SNP uniquely
maps in the chimpanzee genome, certain parameters needed to
be satisfied in the process of the MegaBLAST search results
(see Materials and methods). This resulted in the final set of
1,785,712 SNPs used in this study. The frequencies of two
mutation types in a pair (e.g., G→Aversus C→T) were nearly
the same in our analysis, indicating that the number of SNPs
was sufficient. In addition, we had applied more stringent
criteria to determine the ancestral information of SNPs and
found the results were essentially the same. For example, in the
SNP mapping procedure, we extended the criteria described
under Materials and methods to require that (1) the alignment
length was exactly 201, (2) the identity of the alignment was at
least 98%, (3) no gap was in the alignment, and (4) the position
of the SNP was at the center (i.e., at position 101). This
procedure resulted in 1,072,068 SNPs that generated the same
results (data not shown).
In conclusion, we systematically examined the mutational
spectrum in the whole human genome and categorized regions
using human SNPs. The results revealed how the point
mutations had shifted the nucleotide compositions in the recent
human genome, including the noncoding, exonic, and CpG
island regions. Our results indicate that the previous estimates
based on the limited loci were not accurate and not
representative in the human genome. The comparative analysis
of the u/v ratios suggests that the GC content in the categorized
human genomic regions is not in equilibrium, with a current
trend toward approaching the genome average. Our analysis
provides the first detailed estimate of the mutational spectrum in
the recent human genome and its categorized genomic regions.Materials and methods
Inference of mutation direction by ENCODE data
The human, chimpanzee, and baboon sequences in 44 ENCODE regions
were downloaded from http://genome.ucsc.edu/ENCODE/ (UCSC human
genome assembly hg16). A total of 95,353 human SNPs were also retrieved
from the UCSC ENCODE browser.
Multiple sequence alignments for the human, chimpanzee, and baboon
were carried out using the Multi-LAGAN program [22]. This program, which
is based on a progressive alignment approach and a known phylogenetic tree
for the sequences, can generate highly accurate multiple alignments of long
genomic sequences within a short computational time [22].
A Perl script was written to extract the corresponding chimpanzee and
baboon nucleotides for each human SNP from the alignments. To infer the
mutation direction, we compared each human SNP with the chimpanzee
allele using the baboon as an additional outgroup. We selected the SNPs of
which one of their two alleles matched the chimpanzee allele. Next, the
mutation direction was inferred by the maximum parsimony principle, as
illustrated in Fig. 1.Sequence and SNP data
The assembled human and chimpanzee genomic sequences were down-
loaded from ftp://ftp.ncbi.nih.gov/genomes/ (human build 35 version 1, released
on August 26, 2004; chimpanzee build 1 version 1, released on November 23,
2004). To organize the data effectively, for all the genomic elements (e.g.,
repeats, SNPs, genes, CpG islands) analyzed in this study, we referred their
locations to the assembled reference sequences.
To retrieve the repeat information in the genomic sequences, we downloaded
two files: “masking_coordinates.gz,” which listed the locations of the repetitive
sequences on each contig, and “seq_contig.md,” which listed the locations and
orientations of the contigs across each chromosome. The coordinates of the
repetitive sequences in each chromosome were obtained by combining the
information in these two files.
The human SNPs in XML format were downloaded from ftp://ftp.ncbi.nih.
gov/snp/ (NCBI dbSNP build 124, released on January 6, 2005). A total of
8,353,499 reference SNPs were available; among them, 98.6% (8,234,647
SNPs) were biallelic and uniquely mapped in the genome, and 59.1%
(4,934,380 SNPs) were validated. The location of each SNP was determined
by comparing the SNP position in the contig sequence and the contig location in
the reference sequences. To make sure these annotations were accurate and
matched correctly, we tested them using a method from our previous study [23].
To briefly summarize, (1) a set of SNPs was randomly chosen, (2) then, BLAST
searches of the SNP flanking sequences were performed over the reference
sequences, and (3) the search results were compared with the sequences
extracted directly from the reference sequences based on the locations of SNPs.
Finally, we excluded the SNPs in the repetitive sequences by comparing
SNP locations and repeat coordinates in the reference sequences. This gave
2,646,337 SNPs in the nonrepetitive sequences. We selected 2,632,415 SNPs
whose flanking sequences were at least 100 nucleotides at each side and
formatted them to have 100 nucleotides at each side.
Identification of SNPs in exonic, intronic, and intergenic regions
The gene annotations, including the start and end positions of genes and
exons, were retrieved from the ENSEMBL database (ftp://ftp.ensembl.org/pub/,
version 32.35e, released in July 2005). To identify SNPs in genic, exonic,
intronic, and intergenic regions, stringent criteria were applied. First, we utilized
only known genes and exons in the known genes. Second, since some genes
have alternative transcripts, we selected only those introns that did not contain
any exonic sequences. Third, intergenic regions were selected if there was no
known or predicted gene overlapping with them. Fourth, we categorized the
processed SNPs by comparing SNP locations with the coordinates of each
categorized region. We identified 1,706,674, 496,160, 18,368, and 608,748
SNPs in intergenic, genic, exonic, and intronic regions, respectively.
Identification of SNPs in CpG islands
CpG islands were identified using the CpG island searcher program
(CpGi130) available at http://cpgislands.usc.edu/ [24]. We used stringent search
criteria for GC content ≥55%, ObsCpG/ExpCpG ≥0.65, and length ≥500 bp to
screen CpG islands in the human genome sequences. The criteria above can
effectively exclude the universal Alu repeats, which typically have a sequence
length of 300 bp, GC content of 53%, and ObsCpG/ExpCpG ratio of 0.62 [25,26].
A total of 37,503 CpG islands were identified; among them, 4722 CpG islands
were located or overlapped in the promoter regions (i.e., 2-kb upstream
sequences from the start codon). Next, we identified the processed SNPs in these
CpG islands by matching the coordinates of SNPs with those of the CpG islands
in the reference sequences. We identified 46,060 SNPs in the CpG islands and
4737 SNPs in the promoter associated CpG islands.
Mapping human SNPs to the chimpanzee genome
Because the sequence similarity between the human and the chimpanzee is
very high (e.g., ∼99%) [27], we chose MegaBLAST [28] to map human SNPs
and their flanking sequences to the chimpanzee genome. This is the standard
SNP mapping method in the dbSNP database [29]. The MegaBLAST searches
534 C. Jiang, Z. Zhao / Genomics 88 (2006) 527–534were performed by the following command: megablast –X 180 –r 10 –q −20 –R
T –U T –F m –e 1e−80 –d database –i input_file –o output_file.
We filtered the repetitive sequences in the input sequence files, used an E
value of −80, and increased the X-drop-off value (X) to 180. This generated the
best mapping results (data not shown).
A SNP was considered to “match” when the high-scoring segment pairs
(HSPs) satisfied the following criteria: (1) identity was ≥95%; (2) the
alignment length was between 196 and 206; (3) the SNP site was located
approximately in the center of the alignment, i.e., within 96–106; (4) the
corresponding chimpanzee allele matched one of the SNP alleles; (5) the
immediately adjacent five nucleotides at the 5′ and 3′ sides of the SNP were
identical between the human and the chimpanzee sequences; and (6) only one
HSP satisfied these criteria.
Perl scripts were written to retrieve the human SNPs and their
corresponding chimpanzee alleles from the satisfactory HSPs and to infer
the mutation direction. Perl scripts and the processed data are available upon
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